These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 8461282)

  • 1. Tranylcypromine withdrawal phenomena.
    Halle MT; Dilsaver SC
    J Psychiatry Neurosci; 1993 Jan; 18(1):49-50. PubMed ID: 8461282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Elderly patients, classical monoamine oxidase inhibitors and intercurrent somatic diseases].
    Oostervink F; Bouvy PF; Touw DJ
    Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1937-40. PubMed ID: 14574773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tranylcypromine discontinuation symptoms and withdrawal delirium.
    Freudenmann RW; Baumgarten E; Hawlik AE; Schönfeldt-Lecuona C; Gahr M
    J Clin Psychopharmacol; 2013 Aug; 33(4):574-6. PubMed ID: 23771195
    [No Abstract]   [Full Text] [Related]  

  • 4. [Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review].
    García-Campayo JJ; Sanz-Carrillo C; Ferrández Payo M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(4):217-22. PubMed ID: 7484306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic malignant syndrome without neuroleptics.
    Parsa MA; Rohr T; Ramirez LF; Meltzer HY
    J Clin Psychopharmacol; 1990 Dec; 10(6):437-8. PubMed ID: 2286714
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression.
    Adli M; Pilhatsch M; Bauer M; Köberle U; Ricken R; Janssen G; Ulrich S; Bschor T
    Pharmacopsychiatry; 2008 Nov; 41(6):252-7. PubMed ID: 19067263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoinduction of hypertensive reactions by tranylcypromine?
    Keck PE; Pope HG; Nierenberg AA
    J Clin Psychopharmacol; 1989 Feb; 9(1):48-51. PubMed ID: 2486182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Withdrawal from high-dose tranylcypromine.
    Eyer F; Jetzinger E; Pfab R; Zilker T
    Clin Toxicol (Phila); 2008 Mar; 46(3):261-3. PubMed ID: 18344110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression].
    Nolen WA
    Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1940-3. PubMed ID: 14574774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].
    Volz HP; Gleiter CH; Möller HJ
    Nervenarzt; 1996 May; 67(5):339-47. PubMed ID: 9005342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid conversion from one monoamine oxidase inhibitor to another.
    Szuba MP; Hornig-Rohan M; Amsterdam JD
    J Clin Psychiatry; 1997 Jul; 58(7):307-10. PubMed ID: 9269251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse reactions to monoamine oxidase inhibitors. Part I. A comparative study.
    Rabkin J; Quitkin F; Harrison W; Tricamo E; McGrath P
    J Clin Psychopharmacol; 1984 Oct; 4(5):270-8. PubMed ID: 6386898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refractory depression treated with high doses of monoamine oxidase inhibitor.
    Guze BH; Baxter LR; Rego J
    J Clin Psychiatry; 1987 Jan; 48(1):31-2. PubMed ID: 3804984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Spontaneous' hypertensive episodes with monoamine oxidase inhibitors.
    Fallon B; Foote B; Walsh BT; Roose SP
    J Clin Psychiatry; 1988 Apr; 49(4):163-5. PubMed ID: 3281932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disseminated intravascular coagulation and acute myoglobinuric renal failure: a consequence of the serotonergic syndrome.
    Miller F; Friedman R; Tanenbaum J; Griffin A
    J Clin Psychopharmacol; 1991 Aug; 11(4):277-9. PubMed ID: 1918432
    [No Abstract]   [Full Text] [Related]  

  • 16. MAO inhibition as antidepressive mechanism reevaluated. A controlled study with tranylcypromine isomers.
    Beckmann H; Moises HW
    Mod Probl Pharmacopsychiatry; 1983; 19():211-4. PubMed ID: 6865965
    [No Abstract]   [Full Text] [Related]  

  • 17. Delirium, thrombocytopenia, insomnia, and mild liver damage associated with MAOI withdrawal.
    Bellon A; Coverdale JH
    Eur J Clin Pharmacol; 2009 Dec; 65(12):1269-70. PubMed ID: 19655131
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of MAOI hypertensive crisis with sublingual nifedipine.
    Clary C; Schweizer E
    J Clin Psychiatry; 1987 Jun; 48(6):249-50. PubMed ID: 3584082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptoms of major depression: acute effect of withdrawing antidepressants.
    Halle MH; Del Medico VJ; Dilsaver SC
    Acta Psychiatr Scand; 1991 Mar; 83(3):238-9. PubMed ID: 2031468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversibility of MAO inhibition.
    Baxter LR
    J Clin Psychiatry; 1984 May; 45(5):234. PubMed ID: 6725215
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.